Found: 127
Select item for more details and to access through your institution.
Diabetic retinopathy.
- Published in:
- Diabetes & Primary Care, 2023, v. 25, n. 3, p. 73
- By:
- Publication type:
- Article
44.2: Invited Paper: Printed Polymer TFTs Towards Low‐Cost Backplane Production.
- Published in:
- SID Symposium Digest of Technical Papers, 2018, v. 49, p. 476, doi. 10.1002/sdtp.12759
- By:
- Publication type:
- Article
Photolithographic Integration of High Performance Polymer Thin-Film Transistors.
- Published in:
- SID Symposium Digest of Technical Papers, 2016, v. 47, n. 1, p. 865, doi. 10.1002/sdtp.10819
- By:
- Publication type:
- Article
Printable Organic Thin Film Transistor Backplanes for Mass Produced Displays.
- Published in:
- SID Symposium Digest of Technical Papers, 2012, v. 43, n. 1, p. 422, doi. 10.1002/j.2168-0159.2012.tb05806.x
- By:
- Publication type:
- Article
Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials.
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12933-020-01106-4
- By:
- Publication type:
- Article
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0871-8
- By:
- Publication type:
- Article
Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 7, p. 1639, doi. 10.1007/s13300-024-01590-x
- By:
- Publication type:
- Article
Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 4, p. 869, doi. 10.1007/s13300-024-01551-4
- By:
- Publication type:
- Article
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 5, p. 1099, doi. 10.1007/s13300-024-01550-5
- By:
- Publication type:
- Article
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 889, doi. 10.1007/s13300-022-01242-y
- By:
- Publication type:
- Article
The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 847, doi. 10.1007/s13300-022-01228-w
- By:
- Publication type:
- Article
Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 2, p. 225, doi. 10.1007/s13300-021-01201-z
- By:
- Publication type:
- Article
Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 9, p. 2267, doi. 10.1007/s13300-021-01116-9
- By:
- Publication type:
- Article
One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 6, p. 1593, doi. 10.1007/s13300-021-01061-7
- By:
- Publication type:
- Article
Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 3, p. 801, doi. 10.1007/s13300-021-01015-z
- By:
- Publication type:
- Article
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 1, p. 143, doi. 10.1007/s13300-020-00981-0
- By:
- Publication type:
- Article
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 1, p. 259, doi. 10.1007/s13300-019-00736-6
- By:
- Publication type:
- Article
Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 1, p. 107, doi. 10.1007/s13300-018-0531-0
- By:
- Publication type:
- Article
IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy.
- Published in:
- Diabetes Therapy, 2015, v. 6, n. 4, p. 573, doi. 10.1007/s13300-015-0142-y
- By:
- Publication type:
- Article
The Clinical Development Program of Lixisenatide: A Once-Daily Glucagon-Like Peptide-1 Receptor Agonist.
- Published in:
- Diabetes Therapy, 2014, v. 5, n. 2, p. 367, doi. 10.1007/s13300-014-0073-z
- By:
- Publication type:
- Article
Poor glycaemic control is associated with reduced exercise performance and oxygen economy during cardio-pulmonary exercise testing in people with type 1 diabetes.
- Published in:
- Diabetology & Metabolic Syndrome, 2017, v. 9, p. 1, doi. 10.1186/s13098-017-0294-1
- By:
- Publication type:
- Article
A practical approach to identification of susceptibility genes for IDDM.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Fat – pharmacological therapies.
- Published in:
- British Journal of Diabetes, 2022, v. 22, p. S59, doi. 10.15277/bjd.2022.367
- By:
- Publication type:
- Article
The place of glucagon-like 1 peptide receptor agonists (GLP-1RAs) in the new NICE guidelines - what is going on?
- Published in:
- British Journal of Diabetes, 2022, v. 22, n. 2, p. 69, doi. 10.15277/bjd.2022.381
- By:
- Publication type:
- Article
Changes in Plasma Levels of N-Arachidonoyl Ethanolamine and N-Palmitoylethanolamine following Bariatric Surgery in Morbidly Obese Females with Impaired Glucose Homeostasis.
- Published in:
- Journal of Diabetes Research, 2015, v. 2015, p. 1, doi. 10.1155/2015/680867
- By:
- Publication type:
- Article
Ageing well with diabetes: A workshop to co‐design research recommendations for improving the diabetes care of older people.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 7, p. 1, doi. 10.1111/dme.14795
- By:
- Publication type:
- Article
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 4, p. 1, doi. 10.1111/dme.14769
- By:
- Publication type:
- Article
Cardiovascular risk factors early in the course of treatment in people with type 2 diabetes without established cardiovascular disease: A population-based observational retrospective cohort study.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 3, p. 1, doi. 10.1111/dme.14697
- By:
- Publication type:
- Article
A woman with poorly controlled type 1 diabetes and pruritic papules on her buttocks.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 6, p. 1, doi. 10.1111/dme.14523
- By:
- Publication type:
- Article
Properties of GLP-1 agonists and their use in type 2 diabetes.
- Published in:
- Prescriber, 2016, v. 27, n. 1, p. 43, doi. 10.1002/psb.1430
- By:
- Publication type:
- Article
Dulaglutide: a once-weekly GLP-1 for type 2 diabetes.
- Published in:
- Prescriber, 2015, v. 26, n. 19, p. 28, doi. 10.1002/psb.1393
- By:
- Publication type:
- Article
The place for rapid-acting insulins in therapy.
- Published in:
- Prescriber, 2015, v. 26, n. 8, p. 27, doi. 10.1002/psb.1342
- By:
- Publication type:
- Article
EXPERIMENTAL AGENTS IN TYPE 2 DIABETES: THE NEXT 20 YEARS.
- Published in:
- West London Medical Journal, 2010, v. 2, n. 3, p. 29
- By:
- Publication type:
- Article
INCRETIN THERAPEUTICS IN DIABETES: 1902 TO PRESENT.
- Published in:
- West London Medical Journal, 2010, v. 2, n. 2, p. 15
- By:
- Publication type:
- Article
Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01949-7
- By:
- Publication type:
- Article
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 895, doi. 10.1007/s10198-022-01514-1
- By:
- Publication type:
- Article
Impact of severe hypoglycaemia requiring hospitalization on mortality in people with type 1 diabetes: A national retrospective observational cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2243, doi. 10.1111/dom.15102
- By:
- Publication type:
- Article
Metabolic and physiological responses to graded exercise testing in individuals with type 1 diabetes using insulin pump therapy.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 878, doi. 10.1111/dom.14938
- By:
- Publication type:
- Article
The challenges and pitfalls of incorporating evidence from cardiovascular outcomes trials in health economic modelling of type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 639, doi. 10.1111/dom.14917
- By:
- Publication type:
- Article
Recent developments in GLP‐1RA therapy: A review of the latest evidence of efficacy and safety and differences within the class.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, p. 30, doi. 10.1111/dom.14487
- By:
- Publication type:
- Article
Recent developments in GLP‐1RA therapy: A review of the latest evidence of efficacy and safety and differences within the class.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, p. 30, doi. 10.1111/dom.14487
- By:
- Publication type:
- Article
Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2487, doi. 10.1111/dom.14160
- By:
- Publication type:
- Article
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2193, doi. 10.1111/dom.14140
- By:
- Publication type:
- Article